Insomnia Therapeutics Drugs Market, Global Outlook and Forecast 2023-2029

This report aims to provide a comprehensive presentation of the global market for Insomnia Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Therapeutics Drugs. This report contains market size and forecasts of Insomnia Therapeutics Drugs in global, including the following market information:
Global Insomnia Therapeutics Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Insomnia Therapeutics Drugs market was valued at US$ 3006.2 million in 2022 and is projected to reach US$ 3764 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Benzodiazepines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Insomnia Therapeutics Drugs include Takeda Pharmaceutical Company Ltd., Vanda Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sumitomo Dainippon Pharma Co., Ltd, Sanofi and Paratek Pharmaceuticals Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Insomnia Therapeutics Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insomnia Therapeutics Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Insomnia Therapeutics Drugs Market Segment Percentages, by Type, 2022 (%)
    Benzodiazepines
    Nonbenzodiazepines
    Antidepressants
    Orexin Antagonists
    Melatonin Antagonists
    Others
Global Insomnia Therapeutics Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Insomnia Therapeutics Drugs Market Segment Percentages, by Application, 2022 (%)
    Prescription
    Over-the-Counter (OTC)
Global Insomnia Therapeutics Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Insomnia Therapeutics Drugs Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Insomnia Therapeutics Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Insomnia Therapeutics Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Takeda Pharmaceutical Company Ltd.
    Vanda Pharmaceuticals
    Merck & Co., Inc.
    Pfizer Inc.
    Teva Pharmaceutical Industries Ltd.
    Mylan N.V.
    Sumitomo Dainippon Pharma Co., Ltd
    Sanofi
    Paratek Pharmaceuticals Inc.
    Ebb Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Insomnia Therapeutics Drugs, market overview.
Chapter 2: Global Insomnia Therapeutics Drugs market size in revenue.
Chapter 3: Detailed analysis of Insomnia Therapeutics Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Insomnia Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.